Table 2 Genes modulated specifically at day 2
Gene symbol | Gene name | FC | SEM |
|---|---|---|---|
Hla-dmb | Major histocompatibility complex, class II, DM beta | 9.13 | 0.47 |
Fbxl7_predicted | F-box and leucine-rich repeat protein 7 (predicted) | 8.46 | 3.35 |
Acot12 | Acyl-CoA thioesterase 12 | 8.19 | 3.28 |
Prl8a2 | Prolactin family 8, subfamily a, member 2 | 7.86 | 2.22 |
Tmod1 | Tropomodulin 1 | 6.66 | 0.79 |
Sds | Serine dehydratase | 4.57 | 0.71 |
Adcyap1r1 | Adenylate cyclase activating polypeptide 1 receptor 1 | 4.56 | 0.54 |
Sp2 | Sp2 transcription factor | 4.05 | 0.56 |
Vmd2l1_predicted | Vitelliform macular dystrophy 2-like protein 1 (predicted) | 2.80 | 0.32 |
Crh | Corticotropin releasing hormone | 2.65 | 0.26 |
Fzd4 | Frizzled homolog 4 (Drosophila) | 2.64 | 0.14 |
Igfbp5 | Insulin-like growth factor binding protein 5 | 2.44 | 0.30 |
CPG2 | CPG2 protein | 2.32 | 0.08 |
Lss | Lanosterol synthase | 2.27 | 0.08 |
Reln | Reelin | 2.10 | 0.17 |
Atcay_predicted | Ataxia, cerebellar, Cayman type (caytaxin) (predicted) | 2.05 | 0.06 |
Pik3c2g | Phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide | 2.02 | 0.25 |
Fmo2 | Flavin containing monooxygenase 2 | 1.97 | 0.22 |
Slc13a5 | Solute carrier family 13 (sodium-dependent citrate transporter), member 5 | 1.90 | 0.11 |
Xlkd1_predicted | Extra cellular link domain-containing 1 (predicted) | 1.81 | 0.15 |
Vps4a | Vacuolar protein sorting 4a (yeast) | 1.64 | 0.03 |
C1qbp | Complement component 1, q subcomponent binding protein | 1.53 | 0.10 |
Exosc2_predicted | Exosome component 2 (predicted) | 1.52 | 0.10 |
Map3k6_predicted | Mitogen-activated protein kinase kinase kinase 6 (predicted) | 1.51 | 0.09 |
Retnla | Resistin like alpha | 0.05 | 0.03 |
Csrp2 | Cysteine and glycine-rich protein 2 | 0.10 | 0.03 |
Dmrta1_predicted | Doublesex and mab-3 related transcription factor like family A1 (predicted) | 0.11 | 0.00 |
Rax | Retina and anterior neural fold homeobox | 0.13 | 0.04 |
Ide | Insulin degrading enzyme | 0.14 | 0.02 |
Opcml | Opioid-binding protein/cell adhesion molecule-like | 0.17 | 0.01 |
Wdr22_predicted | WD repeat domain 22 (predicted) | 0.18 | 0.05 |
Nova1 | Neuro-oncological ventral antigen 1 | 0.19 | 0.02 |
Fgf20 | Fibroblast growth factor 20 | 0.21 | 0.01 |
Adh6 | Alcohol dehydrogenase 6 (class V) | 0.22 | 0.02 |
Cpg1 | Candidate plasticity gene 1 | 0.22 | 0.04 |
Pfkfb2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 0.27 | 0.10 |
Gpha2 | Glycoprotein hormone alpha 2 | 0.31 | 0.01 |
Myt1l | Myelin transcription factor 1-like | 0.31 | 0.06 |
Npffr2 | Neuropeptide FF receptor 2 | 0.33 | 0.07 |
Csn2 | Casein beta | 0.34 | 0.06 |
Sybl1 | Synaptobrevin-like 1 | 0.34 | 0.04 |
Efcbp2 | Neuronal calcium binding 2 | 0.40 | 0.06 |
Cbr3_predicted | Carbonyl reductase 3 (predicted) | 0.41 | 0.03 |
Alpi | Alkaline phosphatase 1, intestinal, defined by SSR | 0.41 | 0.04 |
Nrxn1 | Neurexin 1 | 0.43 | 0.06 |
Gp2 | Glycoprotein 2 (zymogen granule membrane) | 0.46 | 0.03 |
Cd248_predicted | CD248 antigen, endosialin (predicted) | 0.46 | 0.05 |
Ppfia3 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 | 0.59 | 0.02 |
Zfp580_predicted | Zinc finger protein 580 (predicted) | 0.62 | 0.05 |
Pttg1ip | Pituitary tumour-transforming 1 interacting protein | 0.65 | 0.05 |